Issue 3, 2008

Natural products to drugs: natural product-derived compounds in clinical trials

Abstract

Covering: 2005 to 2007

Natural product and natural product-derived compounds that are being evaluated in clinical trials or are in registration (as at 31st December 2007) have been reviewed, as well as natural product-derived compounds for which clinical trials have been halted or discontinued since 2005. Also discussed are natural product-derived drugs launched since 2005, new natural product templates and late-stage development candidates.

Graphical abstract: Natural products to drugs: natural product-derived compounds in clinical trials

Article information

Article type
Review Article
Submitted
20 Mar 2008
First published
07 May 2008

Nat. Prod. Rep., 2008,25, 475-516

Natural products to drugs: natural product-derived compounds in clinical trials

M. S. Butler, Nat. Prod. Rep., 2008, 25, 475 DOI: 10.1039/B514294F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements